Therapeutic strategies to induce ERα in luminal breast cancer to enhance tamoxifen efficacy

Breast cancer is the most prevalent malignancy and second leading cause of death in women worldwide, with hormone receptor positive luminal breast cancers being the most widespread subtype. While these tumors are generally amenable to endocrine therapy, cellular heterogeneity and acquired ability of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Endocr Relat Cancer
Hlavní autoři: Esakov, Emily L., Hale, James, Richards, Elliott G., Torre-Healy, Luke, Gullapalli, Keerthi, Trivedi, Div, Chumakova, Anastasia, Wessely, Oliver, Jensen, Jan, Lathia, Justin, Reizes, Ofer
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885119/
https://ncbi.nlm.nih.gov/pubmed/31167163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-19-0042
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky